157 related articles for article (PubMed ID: 38015484)
21. Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma.
Lefebvre MN; Borcherding N; Reis RJ; Mou E; Liu V; Jabbari A
Front Immunol; 2023; 14():1228563. PubMed ID: 37654486
[TBL] [Abstract][Full Text] [Related]
22. Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL).
Ghazawi FM; Alghazawi N; Le M; Netchiporouk E; Glassman SJ; Sasseville D; Litvinov IV
Front Oncol; 2019; 9():300. PubMed ID: 31106143
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and prognostic stratification of cutaneous lymphoma.
Miyagaki T
J Dermatol; 2022 Feb; 49(2):210-222. PubMed ID: 34346516
[TBL] [Abstract][Full Text] [Related]
24. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
Burg G; Häffner A; Böni R; Dommann S; Dummer R
Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
[TBL] [Abstract][Full Text] [Related]
25. Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas.
Gumina ME; Hooper MJ; Zhou XA; Koralov SB
J Invest Dermatol; 2024 Apr; 144(4):755-763. PubMed ID: 38149950
[TBL] [Abstract][Full Text] [Related]
26. Health state utilities associated with caring for an individual with cutaneous T-cell lymphoma (CTCL).
Williams K; Gibson A; McNamara L; Jones T; Lloyd AJ
J Med Econ; 2020 Oct; 23(10):1142-1150. PubMed ID: 32644862
[TBL] [Abstract][Full Text] [Related]
27. Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T-cell lymphomas.
Azuma K; Ohmi A; Goto-Koshino Y; Tomiyasu H; Ohno K; Chambers JK; Uchida K; Namba H; Nagata M; Nagamine E; Nibe K; Irie M; Tsujimoto H
Vet Comp Oncol; 2022 Mar; 20(1):118-126. PubMed ID: 34250731
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
29. Classification and clinical features in 88 cases of equine cutaneous lymphoma.
Miller CA; Durham AC; Schaffer PA; Ehrhart EJ; Powers BE; Duncan CG
J Vet Diagn Invest; 2015 Jan; 27(1):86-91. PubMed ID: 25525142
[TBL] [Abstract][Full Text] [Related]
30. Primary Cutaneous Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis.
Win KT; Liau JY; Chen BJ; Takata K; Chen CY; Li CC; Hsiao CH; Chuang SS
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):105-11. PubMed ID: 25710587
[TBL] [Abstract][Full Text] [Related]
31. Primary cutaneous T-cell lymphoma occurring after organ transplantation.
Ravat FE; Spittle MF; Russell-Jones R
J Am Acad Dermatol; 2006 Apr; 54(4):668-75. PubMed ID: 16546591
[TBL] [Abstract][Full Text] [Related]
32. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma.
Glinos G; Wei G; Nosewicz J; Abdulla F; Chen PL; Chung C; Kaffenberger BH; Querfeld C; Shinohara MM; Sokol L; Zain J; Kumar A; Seminario-Vidal L
JAMA Dermatol; 2023 Feb; 159(2):192-197. PubMed ID: 36598766
[TBL] [Abstract][Full Text] [Related]
35. Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.
Damsky WE; Choi J
Curr Treat Options Oncol; 2016 Jul; 17(7):33. PubMed ID: 27262707
[TBL] [Abstract][Full Text] [Related]
36. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.
Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F
Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life and economic implications of cutaneous T-cell lymphoma.
Semenov YR; Rosenberg AR; Herbosa C; Mehta-Shah N; Musiek AC
Br J Dermatol; 2020 Jan; 182(1):190-196. PubMed ID: 30920642
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous T-cell lymphoma.
Kotz EA; Anderson D; Thiers BH
J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):131-7. PubMed ID: 12705741
[TBL] [Abstract][Full Text] [Related]
39. Recent advances on cutaneous lymphoma epidemiology.
Dobos G; Miladi M; Michel L; Ram-Wolff C; Battistella M; Bagot M; de Masson A
Presse Med; 2022 Mar; 51(1):104108. PubMed ID: 35026392
[TBL] [Abstract][Full Text] [Related]
40. Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma.
Takahashi N; Sugaya M; Suga H; Oka T; Kawaguchi M; Miyagaki T; Fujita H; Sato S
Cancer Res; 2016 Nov; 76(21):6241-6252. PubMed ID: 27634769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
